Canadian study demonstrates new approach to achieving diabet...( Hamilton ON (June 14 2005) Results o...),Health

Hamilton, ON (June 14, 2005) Results of an all-Canadian study announced June 13 at an international diabetes congress demonstrate that patients with type 2 diabetes can safely achieve target blood sugar (glycemic) levels faster and more frequently when insulin glargine (a basal, long-acting insulin) is added to therapy, versus using oral agents alone. In addition to achieving better glycemic control, patients using insulin glargine expressed increased satisfaction with their treatment and experienced improved quality of life.

The INSIGHT study (Implementing New Strategies with Insulin Glargine for Hyperglycemia Therapy), presented at the 65th American Diabetes Association Annual Meeting and Scientific Sessions by lead investigator, Dr. Hertzel Gerstein, a professor of medicine and director of endocrinology and metabolism at McMaster University in Hamilton, demonstrated that early addition of insulin glargine therapy (in combination with oral agents or alone) safely achieved better glycemic and metabolic outcomes than adding oral agents. These results were achieved with no increased risk of hypoglycemia (low blood sugar levels) compared to oral medications.

"Often, insulin therapy is considered as a last resort during late-stage disease," said Dr. Gerstein. "What INSIGHT has shown is that basal insulin therapy with insulin glargine can be safely and effectively introduced early in the course of diabetes. These results may help change the way that type 2 diabetes is managed in the future."

All patients in the study had an A1C (target glycemic level) between seven and 11 per cent. This is above the recommended target of seven per cent or less, established by the Canadian Diabetes Association in the 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. When insulin glargine was added to their treatment, patients were able to achieve lower and steady blood glucose levels more quickly and more often.
'"/>

Contact: Veronica McGuire
vmcguir@mcmaster.ca
905 525-9140 22169
McMaster University
14-Jun-2005

Page: 1 2
Related medicine news :

1. Managing and preventing obesity in Canadian adults and children
2. Canadian study shows bilingualism has protective effect in delaying onset of dementia by four years
3. OPICAN study in seven Canadian cities reveals prescription opioid abuse more prevalent than heroin
4. Most Canadian med school grads lack basic surgical skills
5. Canadian study demonstrates medical induction of labor increases risk of amniotic-fluid embolism
6. Health researchers working to improve the lives of the most vulnerable Canadians
7. Canadian Blood Services scientist invents potential alternative for high-demand blood product
8. First Canadian professorship in melanoma research established
9. $900,000 for first Canadian Chair in Hypertension Prevention and Control
10. CIHR launches casebooks about Canadians turning research into action
11. Sacking of Canadian Medical Association Journals editors deeply troubling